Ken Rollins

Partner in Charge – San Diego
Full contact info

I am an extension of my clients, serving as an advisor at critical inflection points as my clients grow and succeed.

Passions

Family

Motorcycles

Running

Experience

Capstan Therapeutics Announces up to $2.1 Billion Acquisition by AbbVie

June 30, 2025

Cooley advised Capstan Therapeutics, a clinical-stage biotechnology company with a mission to multiply therapeutic possibilities for patients through targeted in vivo RNA technologies, on its definitive agreement to be acquired by AbbVie.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Ken Rollins
Partner in Charge – San Diego, San Diego
Edmond Lay
Partner, San Diego
Charity Williams
Partner, San Diego
Lindsey O'Crump
Associate, Washington, DC
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Christopher Kimball
Partner, Washington, DC
Alessandra Murata
Partner, Palo Alto
W. Chad Shear
Partner, San Diego
Jeffrey J. Tolin
Partner, New York
Stacey A. Bradford
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Rachel Thorn
Of counsel, New York
Alexandria Ashour
Associate, San Diego
Navya Dasari
Associate, New York
Joshua Elefant
Associate, Palo Alto
Tony P. Guan
Associate, Santa Monica
Michelle Hunt
Associate
Emily Mok
Associate, Reston
Jonathan Perez-Reyzin
Associate, San Diego
Breanna Qin
Associate, Palo Alto
Christopher Suhler
Associate, Colorado
Novak Topalovic
Associate, San Diego
Heidi E. Wang
Associate, San Diego
Rubin Waranch
Associate, Colorado
Yuhan Wu
Associate, Palo Alto
Joanna Zhang
Associate, San Diego
Jessica Wade
Paralegal Specialist, San Diego

Related Practices & Industries

Design Therapeutics $125 million Series B Financing and $240 million IPO

Cooley advised Design Therapeutics on its $125 million Series B financing and $240 million IPO. Partner Ken Rollins led the Cooley team advising Design Therapeutics, a preclinical-stage biopharmaceutical company.

 

Related contacts

Ken Rollins
Partner in Charge – San Diego, San Diego

Related Practices & Industries

Silverback Therapeutics: $242 million Initial Public Offering

Silverback Therapeutics, a clinical-stage biopharmaceutical company, in its $242 million IPO.

Related contacts

Ken Rollins
Partner in Charge – San Diego, San Diego

Related Practices & Industries

VelosBio Agrees to Sell to Merck for $2.75 Billion

November 9, 2020

Cooley advised VelosBio, a clinical-stage biopharmaceutical company, on its agreement to sell to Merck, through a subsidiary, for $2.75 billion. Cooley lawyers Barbara Borden, Ken Rollins and Rowook Park led the team advising VelosBio on the transaction, which is expected to close by the end of 2020.

Read more

Related contacts

Barbara Borden
Senior Counsel, San Diego
Ken Rollins
Partner in Charge – San Diego, San Diego
Rowook Park
Partner, San Diego
Rajdeep Roger Bains
Associate, San Diego
David Burns
Special Counsel, Washington, DC
Ross Eberly
Partner, Santa Monica
Vince Flynn
Associate, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Jeffrey J. Tolin
Partner, New York

Related Practices & Industries

Synthorx: $63 Million Series C Financing

April 30, 2018

Synthorx, a developer of protein therapeutics, in its $63 million Series C financing.

Related contacts

Ken Rollins
Partner in Charge – San Diego, San Diego
Asa Henin
Partner, San Diego
View more

Admissions and credentials

California

Rankings and accolades

San Diego Business Journal: SD 500 – The Most Influential People in San Diego (2024)